New hope for young adults with hard-to-treat obesity: drug plus lifestyle beats lifestyle alone
Disease control
Completed
This study tested whether adding the drug semaglutide to lifestyle counseling helps young adults (18-28) with early-onset obesity who previously did not lose enough weight through lifestyle changes alone. About 180-270 participants were split into groups based on their past respo…
Phase: PHASE4 • Sponsor: Signe Torekov • Aim: Disease control
Last updated May 13, 2026 16:02 UTC